Samuel Rivero-Hinojosa

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 12

Top Topics

Transcription Factor

Cancer Stem Cells

Top Venues

International journal of molecular sciences

Nature communications

Journal of the National Cancer Institute

This page only lists publications with an associated author ORCID identifier.

Publications

Elena M Pugacheva, Dharmendra Nath Bhatt, Samuel Rivero-Hinojosa, Md Tajmul, Liron Fedida, Emma Price, Yon Ji, Dmitri Loukinov, Alexander V Strunnikov, Bing Ren, Victor V Lobanenkov
BORIS/CTCFL epigenetically reprograms clustered CTCF binding sites into alternative transcriptional start sites. Genome biology 25 (1) (2024)
Elena M Pugacheva, Dharmendra Nath Bhatt, Samuel Rivero-Hinojosa, Md Tajmul, Liron Fedida, Emma Price, Yon Ji, Dmitri Loukinov, Alexander V Strunnikov, Bing Ren, Victor V Lobanenkov
BORIS/CTCFL epigenetically reprograms clustered CTCF binding sites into alternative transcriptional start sites. Genome biology 25 (1) (2024)
Elena M Pugacheva, Dharmendra Nath Bhatt, Samuel Rivero-Hinojosa, Md Tajmul, Liron Fedida, Emma Price, Yon Ji, Dmitri Loukinov, Alexander V Strunnikov, Bing Ren, Victor V Lobanenkov
BORIS/CTCFL epigenetically reprograms clustered CTCF binding sites into alternative transcriptional start sites. Genome biology 25 (1) (2024)
Elena M Pugacheva, Dharmendra Nath Bhatt, Samuel Rivero-Hinojosa, Md Tajmul, Liron Fedida, Emma Price, Yon Ji, Dmitri Loukinov, Alexander V Strunnikov, Bing Ren, Victor V Lobanenkov
BORIS/CTCFL epigenetically reprograms clustered CTCF binding sites into alternative transcriptional start sites. Genome biology 25 (1) (2024)
Dmitri Loukinov, Amanda Laust Anderson, Mikayel Mkrtichyan, Anahit Ghochikyan, Samuel Rivero-Hinojosa, Jo Tucker, Victor V Lobanenkov, Michael G Agadjanyan, Edward L Nelson
A Therapeutic Vaccine Targeting Rat BORIS (CTCFL) for the Treatment of Rat Breast Cancer Tumors. International journal of molecular sciences 24 (6) (2023)
Dmitri Loukinov, Amanda Laust Anderson, Mikayel Mkrtichyan, Anahit Ghochikyan, Samuel Rivero-Hinojosa, Jo Tucker, Victor V Lobanenkov, Michael G Agadjanyan, Edward L Nelson
A Therapeutic Vaccine Targeting Rat BORIS (CTCFL) for the Treatment of Rat Breast Cancer Tumors. International journal of molecular sciences 24 (6) (2023)
Dmitri Loukinov, Amanda Laust Anderson, Mikayel Mkrtichyan, Anahit Ghochikyan, Samuel Rivero-Hinojosa, Jo Tucker, Victor V Lobanenkov, Michael G Agadjanyan, Edward L Nelson
A Therapeutic Vaccine Targeting Rat BORIS (CTCFL) for the Treatment of Rat Breast Cancer Tumors. International journal of molecular sciences 24 (6) (2023)
Zhenhua Xu, Najiba Murad, Daniel Malawsky, Ran Tao, Samuel Rivero-Hinojosa, Dörthe Holdhof, Ulrich Schüller, Peng Zhang, Christopher A Lazarski, Brian R Rood, Roger Packer, Timothy R Gershon, Yanxin Pei
OLIG2 Is a Determinant for the Relapse of MYC-Amplified Medulloblastoma. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (19) (2022)
Yingchao Xue, Yi Fu, Fenghong Zhao, Gege Gui, Yuguo Li, Samuel Rivero-Hinojosa, Guanshu Liu, Yunqing Li, Shuli Xia, Charles G Eberhart, Mingyao Ying
Frondoside A Inhibits an MYC-Driven Medulloblastoma Model Derived from Human-Induced Pluripotent Stem Cells. Molecular cancer therapeutics 20 (6) (2021)
Samuel Rivero-Hinojosa, Melanie Grant, Aswini Panigrahi, Huizhen Zhang, Veronika Caisova, Catherine M Bollard, Brian R Rood
Proteogenomic discovery of neoantigens facilitates personalized multi-antigen targeted T cell immunotherapy for brain tumors. Nature communications 12 (1) (2021)
Yuting Huang, Samuel Rivero-Hinojosa, Yuchi Ma, Feng Yang, Deliang Fu
RE: Clinical Characteristics and Outcomes of COVID-19-Infected Cancer Patients: A Systematic Review and Meta-Analysis. Journal of the National Cancer Institute 113 (8) (2021)
Samuel Rivero-Hinojosa, Elena M Pugacheva, Sungyun Kang, Claudia Fabiola Méndez-Catalá, Alexander Leonidovich Kovalchuk, Alexander V Strunnikov, Dmitri Loukinov, Jeannie T Lee, Victor V Lobanenkov
The combined action of CTCF and its testis-specific paralog BORIS is essential for spermatogenesis. Nature communications 12 (1) (2021)